Safety and Effectiveness
6
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders
Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach
Clinical and Radiographic Outcomes of the JointMedica Custom-Made Resurfacing Device
Clinical and Radiographic Outcomes of the JointMedica Polymotion Resurfacing (PHR) Device
A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma
The Role of Cycling-cognitive Dual-task Training in Early Parkinson's Disease